re: big us rally in biotechs and drugs Just start to realize that the co now has Pfizer and Sanofi salesforces behind which are quite big. Also the co is treating at a nice profit only 0.5 % of possible eligible US patients and about 0.25 % of eligible patients worldwide so ther is big growth avenues ahead and expansion of P.E ratio
- Forums
- ASX - By Stock
- SRX
- topper's finally got some new material
topper's finally got some new material, page-66
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.40M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $61.98K | 351.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 11238850 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 1266857 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 11238850 | 0.175 |
1 | 164705 | 0.170 |
1 | 18187 | 0.165 |
1 | 2577 | 0.097 |
1 | 4000 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1246997 | 29 |
0.185 | 5000 | 1 |
0.190 | 315669 | 6 |
0.195 | 20478 | 2 |
0.200 | 181416 | 6 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |